Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Anika Therapeutics (ANIK) Debt Ratio (2020 - 2022)

Anika Therapeutics (ANIK) has disclosed Debt Ratio for 7 consecutive years, with 0.01 as the latest value for Q2 2022.

  • Quarterly Debt Ratio fell 73.77% to 0.01 in Q2 2022 from the year-ago period, while the trailing twelve-month figure was 0.01 through Jun 2022, down 73.77% year-over-year, with the annual reading at 0.01 for FY2021, 65.32% down from the prior year.
  • Debt Ratio for Q2 2022 was 0.01 at Anika Therapeutics, down from 0.01 in the prior quarter.
  • The five-year high for Debt Ratio was 0.11 in Q2 2020, with the low at 0.01 in Q3 2021.
  • Average Debt Ratio over 3 years is 0.04, with a median of 0.04 recorded in 2020.
  • The sharpest move saw Debt Ratio crashed 59.07% in 2021, then tumbled 81.67% in 2022.
  • Over 3 years, Debt Ratio stood at 0.04 in 2020, then crashed by 65.32% to 0.01 in 2021, then decreased by 1.86% to 0.01 in 2022.
  • According to Business Quant data, Debt Ratio over the past three periods came in at 0.01, 0.01, and 0.01 for Q2 2022, Q1 2022, and Q4 2021 respectively.